Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer facts & figures 2008.American Cancer Society, Atlanta (GA)2008 (Available at:) (Accessed March 28, 2009)
- Adenomatous lesions of the large bowel: an autopsy survey.Cancer. 1979; 43: 1847-1857
- Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.J Gastroenterol Hepatol. 2008; 23: S198-S204
- Practice parameter on laboratory panel testing for screening and case finding in asymptomatic adults.Arch Pathol Lab Med. 1996; 120: 929-943
- Colorectal cancer screening: health impact and cost effectiveness.Am J Prev Med. 2006; 31 ([PMID: 16777546]): 80-89
- Reducing mortality from colorectal cancer by screening for fecal occult blood.N Engl J Med. 1993; 328: 1365-1371
- Screening and rescreening for colorectal cancer: a controlled trial of fecal occult blood testing in 27,700 subjects.Cancer. 1988; 62: 645-651
- Participation in mass screening for colorectal cancer with fecal occult blood test.Scand J Gastroenterol. 1986; 21: 1180-1184
- Initial mass screening for colorectal cancer with fecal occult blood test: a prospective randomized study at Funen in Denmark.Scand J Gastroenterol. 1987; 22: 677-686
- Repeated screening for colorectal cancer with fecal occult blood test: a prospective randomized study at Fenen, Denmark.Scand J Gastroenterol. 1989; 24: 599-606
- Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test.Scand J Gastroenterol. 1992; 27: 47-52
- Controlled trial of faecal occult blood testing in the detection of colorectal cancer.Lancet. 1983; 2: 1-4
- Randomised, controlled trial of faecal occult blood screening for colorectal cancer: results for first 107,349 subjects.Lancet. 1989; 1: 1160-1164
- Randomised study of screening for colorectal cancer with faecal occult blood test.Lancet. 1996; 348: 1472-1477
- Randomised controlled trial of faecal occult blood screening for colorectal cancer.Lancet. 1996; 348: 1472-1477
- Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.J Natl Cancer Inst. 1999; 91: 434-437
- A-E recommendations for clinical preventive services. Available at.(Accessed March 28, 2009)
- American Cancer Society guidelines for the early detection of cancer.(Available at:) (Accessed March 28, 2009)
- Colorectal cancer screening and surveillance: clinical guidelines and rationale–update based on new evidence.Gastroenterology. 2003; 124: 544-560
- Colorectal cancer: a summary of the evidence for screening and prevention.Am Fam Physician. 2008; 78: 1385-1392
- Screening for colorectal cancer in adults at average risk: a summary of the evidence for US Preventative Services Task Force.Ann Intern Med. 2002; 137: 132-141
- Isolation and characterization of alpha-guaiaconic acid and the nature of guaiacum blue.Phytochemistry. 1971; 10: 2529
- Beckman Coulter. Hemoccult product instruction Available at.(Updated September 2003. Accessed March 28, 2009)
- Noninvasive testing for colorectal cancer: a review.Am J Gastroenterol. 2005; 100: 1393-1403
- False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C).Ann Intern Med. 1975; 83: 824-826
- False-positive guaiac testing with iodine.Arch Pathol Lab Med. 1985; 109: 437-440
- Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting.Ann Intern Med. 1990; 112: 328-333
- Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests.JAMA. 1993; 269: 1262-1267
- Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.Clin Chem. 1999; 45: 123-126
- Screening for colorectal cancer recommendation and rationale.Ann Intern Med. 2002; 137: 96-104
- Cost-effectiveness of CT colonography to screen for colorectal cancer.Agency for Healthcare Research and Quality, Rockville (MD)2009 (Technology Assessment Report Project ID: CTCC0608. Available at) (Accessed March 31, 2009)
- Screening for colorectal cancer: a comparison of 3 fecal occult blood tests.Arch Intern Med. 1997; 157: 970-976
- Comparative screening with a sensitive guaiac and specific immunochemical occult blood test within an endoscopy study.Cancer. 2000; 89: 46-52
- Evaluation of new occult blood tests for detection of colorectal neoplasia.Gastroenterology. 1993; 104: 1661-1668
- Immunochemical versus guaiac occult blood stool tests: results of a community based screening program.Surg Oncol. 1994; 3: 27-36
- Evaluation and comparison of an immunochemical and a guaiac faecal occult blood-screening test for colorectal neoplasia.Eur J Cancer Prev. 1995; 4: 475-481
- Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.Dig Dis Sci. 1997; 42: 2064-2071
- A comparison of fecal occult blood tests for colorectal cancer screening.N Engl J Med. 1996; 334: 155-159
- How long to abstain from eating red meat before fecal occult blood tests.Ann Intern Med. 1990; 113: 403-404
- Improving the fecal occult blood test.N Engl J Med. 1996; 334: 189-190
- Screening for colorectal cancer recommendation statement.Ann Intern Med. 2008; 149: 627-637
- Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies.Am J Gastroenterol. 2002; 97: 2499-2506
- Detection of upper gastrointestinal blood with fecal occult blood tests.Am J Gastroenterol. 1999; 94: 344-350
- Effect of dietary restriction on participation in faecal occult blood test-based screening for colorectal cancer.Med J Aust. 2001; 175: 195-198
- Beckman Coulter. Hemoccult ICT immunochemical fecal occult blood test product instructions. Updated June 2005. Available at.(Accessed March 28, 2009)
- Quantitative immunochemical fecal occult blood tests: is it time to go back to the future [editorial]?.Ann Intern Med. 2007; 146: 309-311
- Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.J Natl Cancer Inst. 2007; 99: 1462-1470
- Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.Ann Intern Med. 2009; 150: 162-169
- CodeMap national for 2008 laboratory fees. Available at.(Accessed March 28, 2009)
- A genetic model for colorectal tumorigenesis.Cell. 1990; 61: 759-767
- Microsatellite instability in colorectal cancer.Br J Surg. 2006; 93: 395-406
- Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.N Engl J Med. 2000; 342: 69-77
- Fecal DNA versus fecal occult blood for colorectal cancer screening in an average-risk population.N Engl J Med. 2004; 351: 2704-2714
- BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines.Cancer Res. 1997; 57: 300-303
- DNA stool testing with DNA Direct. Available at.(Accessed March 28, 2009)
- Stool DNA and occult blood testing for screen detection of colorectal neoplasia.Ann Intern Med. 2008; 149: 441-450
- Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).Transl Res. 2007; 149: 96-102
- A smarter strategy? Reflections on fecal DNA screening for colorectal cancer.N Engl J Med. 2004; 351: 2755-2758
- Fecal DNA for colorectal cancer screening.N Engl J Med. 2005; 352: 1384-1385
- Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation.Ann Fam Med. 2009; 7: 11-16
- Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation.Am J Public Health. 1993; 83: 1620-1622
- Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey.Am J Gastroenterol. 2000; 95: 1551-1556
- Diagnostic testing following fecal occult blood screening in the elderly.J Natl Cancer Inst. 1999; 91: 1641-1646
- Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood.Am J Gastroenterol. 2001; 96: 196-203
- Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical based tests.Am J Med. 2003; 115: 111-114
- Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians.Ann Intern Med. 1997; 126: 811-822
- Challenges in the management of positive fecal occult blood tests.J Gen Intern Med. 2009; 24: 356-360
- Screening for colorectal cancer: an updated systematic review.(Evidence synthese no. 65, part 1. AHRQ publication no. 08-05124-EF-1) Agency for Healthcare Research and Quality, Rockville (MD)2008
Article info
Identification
Copyright
© 2009 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
